Publications by authors named "Athanasios Markopoulos"

Claim this Profile
R
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.
Danilo De Gregorio, Antonio Inserra, Justine P Enns, Athanasios Markopoulos, Michael Pileggi

Neuropsychopharmacology· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.
Athanasios Markopoulos, Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi

Front Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood-brain barrier be a disease "sanctuary" during venetoclax treatment?
Maria Dimou, Aikaterini Bitsani, Maria Roumelioti, Aglaia Dimitrakopoulou, Theodore Iliakis, Athanasios Markopoulos

Clin Case Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.
Danilo De Gregorio, Jelena Popic, Justine P Enns, Antonio Inserra, Agnieszka Skalecka, Athanasios Markopoulos

Proc Natl Acad Sci U S A· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Z (PZ) and plasminogen activator inhibitor-1 (PAI-1) plasma levels in patients with previously untreated Hodgkin lymphoma (HL).
Georgios Boutsikas, Evangelos Terpos, Athanasios Markopoulos, Athanasios Papatheodorou, Angeliki Stefanou

J BUON· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis